• 1. An investigation of the electrochemical delithiation process of carbon coated α-Fe2O3nanoparticles
  Adrian Brandt,Florian Winter,Sebastian Klamor,Frank Berkemeier,Jatinkumar Rana,Rainer P?ttgen,Andrea Balducci J. Mater. Chem. A, 2013,1, 11229-11236
• 2. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148
• 3. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
• 4. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 5. Achieving molecular stability of racemic 4-O-benzyl-myo-inositol-1,3,5-orthoformate through crystal formation?
  Richa Sardessai,Shobhana Krishnaswamy,Mysore S. Shashidhar CrystEngComm, 2012,14, 8010-8016

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Primary alcohols
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alcohols and polyols Primary alcohols

Research Brief on (2,2,6,6-tetramethylcyclohexyl)methanol (CAS: 83357-68-0) in Chemical Biology and Pharmaceutical Applications

The compound (2,2,6,6-tetramethylcyclohexyl)methanol (CAS: 83357-68-0) has recently garnered attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential applications. This research brief aims to synthesize the latest findings on this compound, focusing on its synthesis, biological activity, and potential therapeutic uses. The compound's sterically hindered cyclohexyl structure and hydroxyl functional group make it a promising candidate for various applications, including drug development and material science.

Recent studies have explored the synthetic pathways for (2,2,6,6-tetramethylcyclohexyl)methanol, highlighting its efficient production via catalytic hydrogenation of corresponding ketones or through Grignard reactions. The compound's stability and solubility in organic solvents have been noted, making it a versatile intermediate in organic synthesis. Additionally, its potential as a chiral building block in asymmetric synthesis has been investigated, with promising results in the production of enantiomerically pure pharmaceuticals.

In the realm of biological activity, preliminary studies suggest that (2,2,6,6-tetramethylcyclohexyl)methanol may exhibit moderate antimicrobial properties. Researchers have tested its efficacy against a range of bacterial and fungal strains, with notable activity against Gram-positive bacteria. While the exact mechanism of action remains under investigation, the compound's lipophilic nature is believed to facilitate membrane disruption, leading to microbial cell death. Further studies are needed to elucidate its full spectrum of biological activities and potential therapeutic applications.

From a pharmaceutical perspective, (2,2,6,6-tetramethylcyclohexyl)methanol has been explored as a potential precursor for prodrug development. Its hydroxyl group can be functionalized to improve drug delivery and bioavailability. Recent work has focused on conjugating this compound with known active pharmaceutical ingredients (APIs) to enhance their pharmacokinetic profiles. For instance, researchers have reported successful derivatization with anti-inflammatory agents, resulting in improved solubility and sustained release properties.

The compound's potential in material science has also been investigated. Its rigid, bulky structure makes it an interesting candidate for polymer modification, particularly in the development of high-performance materials with enhanced thermal stability. Studies have demonstrated its utility as a monomer in the synthesis of specialty polyesters and polycarbonates, offering improved mechanical properties compared to conventional materials.

Despite these promising findings, challenges remain in the widespread application of (2,2,6,6-tetramethylcyclohexyl)methanol. Issues such as large-scale synthesis optimization, cost-effectiveness, and comprehensive toxicity profiling need to be addressed. Current research efforts are focusing on green chemistry approaches to improve the compound's synthetic accessibility while minimizing environmental impact.

In conclusion, (2,2,6,6-tetramethylcyclohexyl)methanol (CAS: 83357-68-0) represents a versatile compound with significant potential in chemical biology and pharmaceutical applications. Ongoing research continues to uncover new possibilities for this molecule, from drug development to advanced materials. As investigations progress, this compound may emerge as a valuable tool in addressing various challenges in medicinal chemistry and material science.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)